Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationCyclophosphamideGranulocyte Colony-Stimulating FactorTransplantation ConditioningLeukapheresisTransplantation, HomologousMelphalanBlood Component RemovalAntigens, CD34Hematologic NeoplasmsCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsStem Cell TransplantationMultiple MyelomaGraft vs Host DiseaseHematopoietic Stem CellsBusulfanMyeloablative AgonistsBone Marrow TransplantationTreatment OutcomeGraft SurvivalLymphoma, Non-HodgkinStem CellsEtoposideAntineoplastic Agents, AlkylatingThiotepaRemission InductionRecurrenceIfosfamideCarmustineVincristineCord Blood Stem Cell TransplantationCytophagocytosisHematopoiesisSalvage TherapyCytarabineDisease-Free SurvivalAmyloidosisHodgkin DiseaseTissue DonorsTransplantation ChimeraSurvival RateRetrospective StudiesNeoplasmsDoxorubicinWhole-Body IrradiationBlood Cell CountInfectionPlatelet CountHistocompatibilitySurvival AnalysisTime FactorsBlood CellsRecombinant ProteinsPOEMS SyndromeImmunosuppressive AgentsHistocompatibility TestingVidarabinePrednisoneCarboplatinLymphoma, T-CellTransplantation, IsogeneicLeukemia, Myeloid, AcuteBone Marrow PurgingLeukemiaLymphomaDexamethasoneFollow-Up StudiesAntineoplastic AgentsFeasibility StudiesProspective StudiesCytomegalovirus InfectionsGraft vs Leukemia EffectAnemia, AplasticImmunophenotypingBlood DonorsFatal OutcomeLeukocytes, MononuclearMyelodysplastic SyndromesBone MarrowHematologic DiseasesLymphocyte DepletionLeukocyte CountLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBreast NeoplasmsCell SeparationT-LymphocytesHistiocytosis, Non-Langerhans-CellNeutropeniaFlow CytometryEmbryonic Stem CellsBone Marrow DiseasesImmunomagnetic SeparationCyclosporineOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaFever